Hypermethylation of IL‐10 gene is responsible for its low mRNA expression in Behçet's disease
Hypermethylation of IL‐10 gene is responsible for its low mRNA expression in Behçet's disease
نویسندگان: شهریار علیپور , محمد نوری , علیرضا خبازی اسکویی , ناصر صمدی , زهره بابالو , سمیه ابوالحسنی , جعفر فرهادی , ندا روشن روان , غلامرضا جدیداسلام , ابراهیم سخی نیا
کلمات کلیدی: Behçet's disease, DNA methylation, IL-10, MeDIP-qPCR
نشریه: 19611 , 8 , 119 , 2018
| نویسنده ثبت کننده مقاله |
شهریار علیپور |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
بیماری های بافت همبند |
| کد مقاله |
63563 |
| عنوان فارسی مقاله |
Hypermethylation of IL‐10 gene is responsible for its low mRNA expression in Behçet's disease |
| عنوان لاتین مقاله |
Hypermethylation of IL‐10 gene is responsible for its low mRNA expression in Behçet's disease |
| ناشر |
10 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Interleukin-10 (IL-10), produced generally by monocyte, T helper type 2 (Th2), and
regulatory T cells (Treg), plays a central role in controlling inflammatory responses and
regulating the immune response of the IL-10 mRNA expression. It is significantly
down-regulated in many autoimmune diseases such as Behçet's disease; this is mostly
associated with more aggressive complications. Nevertheless, the essential molecular
process for its low expression has not been completely realized. The aim of this project
was attempted to estimate the gene expression, promoter methylation, and protein
levels to IL-10's down-regulated expression. In this study, blood samples from 51 (4
missed) patients and 63 (2 missed) healthy controls were taken, with the mononuclear
cells isolated by the Ficoll Protocol. DNA and RNA were then subsequently extracted.
Promoter methylation levels were evaluated by MeDIP-qPCR. Following this, the
extracted RNA was converted to cDNA using the RT-PCR method, with the expression
of IL-10 later evaluated by Real-time PCR. And then, serum levels of IL-10 were
measured using ELISA method. As we expected, the expression level of the IL-10 gene
was seen to significantly decline in the patient group in comparison to the control. Also,
the rate of promoter methylation was significantly higher in the IL-10 mRNA low
expression group (patient group) compared to its high expression group (healthy
group) (P< 0.001). We revealed that hypermethylation of promoter region was the
principal defect for the IL-10 mRNA low expression in patients with Behçet's disease |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| suggestion for my paper prise.jpg | 1397/05/08 | 364034 | دانلود |
| IL10 methylation.pdf | 1397/05/08 | 847754 | دانلود |